Cystic fibrosis: The miracle drugs priced out of reach
Regulators around the world have questioned the high price set by Vertex Pharmaceuticals.
Similar Posts
Healthcare software vendor NextGen explores sale | Reuters News Agency
Business & FinanceDealsHealth 23 August 2023, 2:10 pm 1 minute Reuters exclusively reported that NextGen Healthcare (NXGN.O), a provider of software that helps manage patients’ records, is exploring options that include a sale of the company. Market Impact NextGen shares rose 10% to $18.01 on the news in afternoon trading in New York on Wednesday,…
Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips
Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting.
MoonLake Immunotherapeutics explores sale | Reuters News Agency
Business & FinanceDealsHealth 14 July 2023, 5:43 pm 1 minute MoonLake Immunotherapeutics (MLTX.O), a developer of an antibody-derived treatment for inflammatory skin conditions, is working with an investment bank and having early-stage conversations with drugmakers interested in a potential acquisition. Market Impact MoonLake’s shares ended trading up 8.4% at $54.27 on the news on Friday,…
Eat Out to Help Out: What was the impact of the scheme?
How much did the scheme help the economy and affect the spread of Covid?Â
SEC charges ex-CEO of medical device company with fraud, says some devices were ‘just a piece of plastic’
The headquarters of the U.S. Securities and Exchange Commission (SEC) is seen in Washington, D.C., May 12, 2021. Andrew Kelly | Reuters Laura Tyler Perryman, co-founder and former CEO of the medical device startup Stimwave Technologies, was charged with allegedly defrauding investors out of $41 million by making “false and misleading” statements about one of…
Biden administration’s Medicare drug price negotiations will face major tests in 2024
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images U.S. patients and drugmakers will get a first glimpse of how much Medicare can negotiate down drug prices in 2024, setting the…
